Spark Therapeutics

Status: Active

Company Stats

Tax Status:
For-profit
Info

Company Overview

Status: Active

Company Stats

Expertise:
biomedical
Tax Status:
For-profit

Spark Therapeutics is one of the largest cell and gene therapy companies in the Philadelphia region. The University City-based company was acquired by Roche for $4.8 billion in 2019, Philly’s largest-ever VC backed exit.

Read More

Technical.ly Coverage